Organon & Co opens women’s health company in India

Organon India has been launched in India as a wholly-owned subsidiary of Organon & Co, a global healthcare company focused on meeting the healthcare needs of women. The company will focus its efforts on building a healthier every day for every woman. In India, Organon will be operating in women’s healthcare, fertility, dermatology, respiratory and bone health products in their portfolio. Organon India will be operating with its in-house sales force and alliance partners across the various markets. Organon’s portfolio will consist of more than 60 medicines and products across an international footprint that serves people in more than 140 countries, with nearly 80 per cent of its revenue generated outside the US. Organon is well positioned for organic low-tomid-single digit growth from its 2021 base of business. Organon in India and neighboring markets will firmly stand on its women’s health, fertility and established brands portfolio which will benefit from renewed management focus and enhanced commercial activities.